# Safety and Efficacy of Paclitaxel Coated PTCA Balloon Catheter With a Shellac Plus Vitamin E Excipient (GENOSS® DCB) in Patients With Coronary In-stent Restenosis (ISR): A Prospective, Multi-center, Observational Study

> **NCT06104007** · — · RECRUITING · sponsor: **Seoul National University Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Coronary Artery Disease
- In-stent Restenosis

## Interventions

- **DEVICE:** Genoss® DCB

## Key facts

- **NCT ID:** NCT06104007
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-17
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2023-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06104007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06104007, "Safety and Efficacy of Paclitaxel Coated PTCA Balloon Catheter With a Shellac Plus Vitamin E Excipient (GENOSS® DCB) in Patients With Coronary In-stent Restenosis (ISR): A Prospective, Multi-center, Observational Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06104007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*